Haima Therapeutics LLC

Cell-inspired therapies for bleeding and blood disorders.

Cleveland, United States · Founded 2018 · $4.0M raised

Headquarters
Cleveland, Ohio
Employees
1–10
Founded
2018
Business Model
B2G
Total Funding
$4.0M
Last Round
$4.0M GrantSep 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Haima Therapeutics is a pre-clinical stage biopharma company developing cell-inspired therapies for bleeding and blood-related diseases. Its lead technology, SynthoPlate, is a fully-synthetic nanoparticle-based hemostatic agent that mimics platelet function to control hemorrhagic bleeding after trauma, surgery, or in rare bleeding disorders. The company has received SBIR funding from DARPA, NIH, and NSF to advance SynthoPlate toward first-in-human clinical trials.

Summary

Haima Therapeutics LLC is a Biotech company based in Cleveland, United States, founded in 2018. It has raised $4.0M in total across 2 rounds, most recently a $4.0M Grant round in Sep 2025. Investors include Defense Advanced Research Projects Agency and National Institutes of Health.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantSep 2025
$4.0M

Sign up to see all 2 events

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Haima Therapeutics LLC on Indexed.vc
<a href="https://indexed.vc/companies/haima-therapeutics-llc"><img src="https://indexed.vc/api/badge/company/haima-therapeutics-llc" alt="Haima Therapeutics LLC on Indexed.vc" width="260" height="76" /></a>